stockportfolio.pro
Stocks / GRAL vs IRON
GRAL vs IRON
GRAIL, Inc. and Disc Medicine, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| GRAIL, Inc. (GRAL) | Disc Medicine, Inc. (IRON) | |
|---|---|---|
| Market cap | $2.6B | $2.6B |
| Revenue (latest FY) | $147.17M | $0 |
| Net income (latest FY) | $-408.35M | $-212.18M |
| Revenue growth (5y CAGR) | 38.4% | — |
| Net margin | -277.5% | — |
| Return on equity | -15.8% | -28.7% |
| P/E ratio | — | — |
| Dividend yield | — | — |
| Profitable years (of last 10) | 0 | 0 |
| Positive free cash flow | No | No |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open GRAL — free Open IRON — freeFrequently asked questions
Which is bigger, GRAL or IRON?
GRAIL, Inc. is larger by market capitalization — $2.6B versus $2.6B.
Which grows faster, GRAL or IRON?
Five-year growth data is not available for both companies.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.